Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
MPR

Levacetylleucine Shows Promise for Treatment of Ataxia-Telangiectasia

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

Essential Tremor Management: From Pharmacotherapy to Surgery and More

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...
Hosted on MSN

What is ataxia? Doctor explains symptoms triggered by lesions in brain

Ataxia is a condition caused by damage in cerebellum, a part of the brain, that leads to poor muscle control affecting movement. In an interview with HT Lifestyle, Dr Aniruddha More, consultant ...
News Medical on MSN

CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...
Health.com

What Causes Chills Without Fever?

Amanda Gardner is a health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine, the Foreign ...